Literature DB >> 24677745

Clinical manifestations of 17 patients affected with mucopolysaccharidosis type VI and eight novel ARSB mutations.

Piranit Nik Kantaputra1, Hulya Kayserili, Yeliz Guven, Warissara Kantaputra, Mehmet C Balci, Pranoot Tanpaiboon, Napaporn Tananuvat, Anusha Uttarilli, Ashwin Dalal.   

Abstract

Mucopolysaccharidosis (MPS) type VI or Maroteaux-Lamy syndrome is a very rare autosomal recessive lysosomal storage disease, caused by a deficiency of the enzyme N-acetylgalactosamine-4-sulfatase (Arylsulfatase B, ARSB). Clinical examination, biochemical studies, and molecular genetic analyses have been performed in 17 patients affected with MPS VI from 15 unrelated families from Thailand, India, and Turkey. Large ear lobule appears to be a newly recognized finding of this syndrome. Mutation analysis of the ARSB gene revealed seven missense and three frameshift mutations of which eight were novel. Novel missense mutations were p.Asp53Asn, p.Val376Glu, p.Glu390Lys, p.Pro445Leu, and p.Trp450Cys, while an Indian patient was homozygous for two novel missense mutations (p.Pro445Leu and p.Trp450Cys). Three novel frameshift mutations were p.Pro70fsX123, p.Ser403fs, and p.Thr526fs. Two previously reported mutations, p.Arg160Gln and p.Leu321Pro, were also observed in our cohort. The amino acid Arg160 appears to be the mutational hot spot for the ARSB gene. Five patients homozygous for p.Leu321Pro mutation had early onset of the disease, and haplotype analysis showed that the mutation is a founder mutation in Turkish population.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ARSB; MPS VI; Maroteaux-Lamy syndrome; dermatan sulfate; genotype-phenotype correlation; hoarse voice; large ear lobule

Mesh:

Substances:

Year:  2014        PMID: 24677745     DOI: 10.1002/ajmg.a.36489

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  A Novel Pathological ARSB Mutation (c.870G>A; p.Trp290stop) in Mucopolysaccharidosis Type VI Patients.

Authors:  Veysel S Hançer; Murat Büyükdoğan; Anila Babameto-Laku
Journal:  Mol Syndromol       Date:  2019-08-27

2.  Differences in maxillomandibular morphology among patients with mucopolysaccharidoses I, II, III, IV and VI: a retrospective MRI study.

Authors:  Till Koehne; Anja Köhn; Reinhard E Friedrich; Uwe Kordes; Thorsten Schinke; Nicole Muschol; Bärbel Kahl-Nieke
Journal:  Clin Oral Investig       Date:  2017-10-18       Impact factor: 3.573

3.  Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation.

Authors:  Till Koehne; Sarah Müller-Stöver; Anja Köhn; Katharina Stumpfe; Susanne Lezius; Carmen Schmid; Zoltan Lukacs; Bärbel Kahl-Nieke; Nicole Muschol
Journal:  Sleep Breath       Date:  2019-07-22       Impact factor: 2.816

4.  Growth Charts for Individuals with Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome).

Authors:  Adrian Quartel; Christian J Hendriksz; Rossella Parini; Sue Graham; Ping Lin; Paul Harmatz
Journal:  JIMD Rep       Date:  2014-12-18

5.  A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis.

Authors:  Barbara Zapała; Olaf Chmura; Urszula Ciałowicz; Bogdan Solnica; Magdalena Krajewska-Włodarczyk; Zbigniew Żuber
Journal:  Mol Genet Metab Rep       Date:  2020-10-28

6.  Prevalence of anti-adeno-associated virus serotype 8 neutralizing antibodies and arylsulfatase B cross-reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial.

Authors:  Rita Ferla; Pamela Claudiani; Marco Savarese; Karen Kozarsky; Rossella Parini; Maurizio Scarpa; Maria Alice Donati; Giovanni Sorge; John J Hopwood; Giancarlo Parenti; Simona Fecarotta; Vincenzo Nigro; Hatice Serap Sivri; Ans Van Der Ploeg; Generoso Andria; Nicola Brunetti-Pierri; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2015-03       Impact factor: 5.695

Review 7.  Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene.

Authors:  Rosella Tomanin; Litsa Karageorgos; Alessandra Zanetti; Moeenaldeen Al-Sayed; Mitch Bailey; Nicole Miller; Hitoshi Sakuraba; John J Hopwood
Journal:  Hum Mutat       Date:  2018-09-17       Impact factor: 4.878

8.  Clinical implementation of gene panel testing for lysosomal storage diseases.

Authors:  Alexander Gheldof; Sara Seneca; Katrien Stouffs; Willy Lissens; Anna Jansen; Hilde Laeremans; Patrick Verloo; An-Sofie Schoonjans; Marije Meuwissen; Diana Barca; Geert Martens; Linda De Meirleir
Journal:  Mol Genet Genomic Med       Date:  2018-12-11       Impact factor: 2.183

9.  Mutations in ARSB in MPS VI patients in India.

Authors:  Juby Mathew; Sujatha M Jagadeesh; Meenakshi Bhat; S Udhaya Kumar; Saravanamuthu Thiyagarajan; Sudha Srinivasan
Journal:  Mol Genet Metab Rep       Date:  2015-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.